Nucleocapsid R204P Mutation in SARS-CoV-2 Omicron XEC Lineages and Recombinants Enhances Inflammation and Severity!
Nikhil Prasad Fact checked by:Thailand Medical News Team Jun 01, 2025 1 day, 14 hours, 7 minutes ago
Thailand Medical News: A Dangerous Genetic Twist in the Omicron Saga
As the world continues to navigate through the ever-evolving landscape of SARS-CoV-2 variants, scientists are now warning of a new mutation that may escalate the threat posed by the virus. A groundbreaking new study by a global team of researchers has revealed that a mutation in the nucleocapsid protein—specifically the R204P mutation—in the Omicron XEC variant and all its new spawns or recombinants, significantly increases the virus's ability to trigger inflammation and disease severity.
Nucleocapsid R204P Mutation in SARS-CoV-2 Omicron XEC Lineages and
Recombinants Enhances Inflammation and Severity
This
Thailand Medical News report dives into the study conducted by researchers from Kyushu University, Hokkaido University, The University of Tokyo, Kyoto University, Kumamoto University, Gladstone Institutes in San Francisco, the University of California San Francisco, and other institutions affiliated with the Genotype to Phenotype Japan (G2P-Japan) Consortium.
How XEC Emerged and Why It’s Concerning
Omicron XEC, a recombinant strain, emerged in late 2024 from two descendants of the JN.1 lineage—KS.1.1 and KP.3.3. It was first detected in Germany and has since spread rapidly across the globe. While most of the attention has historically been placed on mutations in the spike protein of the virus, which allows it to enter human cells, this study turns the spotlight onto a different part of the virus—the nucleocapsid (N) protein.
The researchers found that the XEC variant, although similar in its spike protein behavior to earlier strains like JN.1, caused more severe symptoms in animal models. The key culprit behind this increased severity? A single mutation in the nucleocapsid protein: R204P.
What Exactly Does the R204P Mutation Do?
The nucleocapsid protein is critical for packaging the virus's genetic material. Changes in this protein can affect how well the virus replicates and how the immune system responds. The R204P mutation in XEC does not increase the replication rate of the virus itself, but it appears to disrupt a key regulatory function that normally prevents the virus from over-activating immune responses.
In laboratory tests and in hamsters infected with the variant, this mutation triggered stronger inflammation in lung tissues. Animals infected with the XEC variant lost more weight, showed more lung damage, and exhibited more intense immune responses compared to those infected with the original JN.1 variant or a genetically engineered XEC variant where the R204P mutation had been removed.
Triggering the Body’s Inflammatory Alarms
One of the most important findings of the study is that the R204P mutation enhances activation of the NF-κB pathway—a critical signaling route in human cells that controls inflammation. Normally, the nucleocapsid protein helps to keep this p
athway in check. But when arginine at position 204 is replaced by proline, this regulatory ability is disrupted.
Through a series of experiments, including the use of airway-on-a-chip models and luciferase assays, the team showed that the mutated version of the nucleocapsid protein led to much higher levels of pro-inflammatory molecules like IL-6, IL-8, IL-1β, and CCL2. These molecules are known to be involved in the kind of "cytokine storm" that has been linked to severe COVID-19 and death.
Implications for Future Variants and Surveillance
Interestingly, the study also found that while the spike protein mutations in XEC are responsible for its spread, the increased severity of disease is more linked to this non-spike mutation. This represents a possible shift in how the virus evolves. The researchers note that the spike protein may be reaching the limit of its ability to mutate while maintaining effectiveness. As a result, SARS-CoV-2 might begin using changes in other proteins, like the nucleocapsid, to adapt and become more virulent.
The authors caution that such mutations could potentially bypass existing immune defenses or create more dangerous recombinants if combined with other immune-evasive features. They emphasize the need for global genomic surveillance to look beyond just the spike protein in monitoring new variants.
The enhanced inflammation caused by XEC may still pose a serious health threat, particularly in vulnerable individuals or those with underlying conditions.
Conclusion
This study underscores a pivotal shift in the evolution of SARS-CoV-2. While earlier waves of the virus relied heavily on spike protein mutations to spread and evade immunity, the Omicron XEC variant is now demonstrating that mutations in other regions of the virus, like the nucleocapsid protein, can drive more severe illness through heightened inflammation. The R204P mutation in the nucleocapsid protein essentially disables an internal check that normally helps to dampen the body’s immune response, unleashing an overreaction that damages tissues, especially in the lungs. This could explain why some patients might experience worse symptoms even if the virus does not replicate more aggressively. As the virus continues to recombine and adapt, it may increasingly rely on such strategies, making future variants potentially more dangerous. The study serves as a warning that comprehensive genomic monitoring—beyond just the spike protein—is crucial to anticipating and preparing for the next phase of the pandemic.
The study findings were published on a preprint server and is currently being peer reviewed.
https://www.biorxiv.org/content/10.1101/2025.05.28.656516v1
For the latest COVID-19 News, keep on logging to
Thailand Medical News.
Read Also:
https://www.thailandmedical.news/news/researchers-discover-mutation-in-sars-cov-2-nsp15-protein-that-enhances-its-ability-to-evade-immunity
https://www.thailandmedical.news/news/sars-cov-2-variant-mutation-in-nsp6-weakens-immune-defenses-and-hijacks-host-cell-signaling
https://www.thailandmedical.news/news/oxidative-rna-damage-in-covid-19-may-be-driving-dangerous-viral-mutations
https://www.thailandmedical.news/articles/coronavirus
https://www.thailandmedical.news/pages/thailand_doctors_listings
Share
Tweet
Share
